Varicella-related Hospitalizations in Turkey
VARICOMP
The Epidemiology and Economic Impact of Varicella Related Hospitalization in Turkey (VARICOMP Study)
1 other identifier
observational
1,800
0 countries
N/A
Brief Summary
Epidemiological information on varicella complications in children is essential for the development of appropriate immunization recommendations. Economic analyses of varicella immunization are sensitive to the costs of hospitalized cases, so there is a need to validate varicella-related hospitalization data in a country-specific manner. These data also provide a baseline for comparison with data collected after routine varicella immunization to evaluate the overall impact and cost-effectiveness of varicella immunization programs. Knowledge about the cause and incidence of varicella-related hospitalizations in Turkey is limited, center-specific and not sufficiently accurate. The aim of this multicenter study (VARICOMP) was to estimate the annual incidence of pediatric varicella-related hospitalization, describe the associated complications and estimate the annual mortality and economic cost of these cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2010
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 12, 2012
CompletedFirst Posted
Study publicly available on registry
June 27, 2013
CompletedJuly 28, 2017
July 1, 2017
2.1 years
November 12, 2012
July 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Annual incidence of varicella-related hospitalization
The primary goal of this study was to estimate the annual incidence of hospitalization resulting from varicella and to describe the associated complications.
Hospitalization rate between 2008-2013 (up to 5 years)
Secondary Outcomes (1)
The cost of varicella-related hospitalization in children.
2008-2013 (up to 5 years)
Study Arms (1)
Chickenpox complications
Cases were identified by International Classification of Disease of the Tenth Revision (ICD-10) diagnostic codes for chickenpox infection or chickenpox-associated complications, if available.
Eligibility Criteria
0-18 years old hospitalized children due to varicella and -related complications
You may qualify if:
- years old hospitalized children due to varicella and -related complications
- Previously healthy or with chronic disease or conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ener C Dinleyici, MD
Eskisehir Osmangazi University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor in Pediatrics
Study Record Dates
First Submitted
November 12, 2012
First Posted
June 27, 2013
Study Start
September 1, 2010
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
July 28, 2017
Record last verified: 2017-07